The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
MedPage Today on MSN
Targeted drug for advanced pancreatic cancer sparks early enthusiasm
The early results showed that 15 of 41 evaluable patients had objective responses and 32 had stable disease with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback